DAWN FOUSE: Open Payments
NPI 1316250590 · CHRISTIANSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,255 in 67 payments from 20 companies in 2025. Trend: 2023 $1,036 · 2024 $1,013 · 2025 $1,255
Food & beverage: $1,255
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $276 |
| Amgen Inc. | 14 | $195 |
| Janssen Pharmaceuticals, Inc | 4 | $106 |
| Abbott Laboratories | 5 | $94 |
| ABBVIE INC. | 4 | $77 |
| PFIZER INC. | 4 | $71 |
| Lilly USA, LLC | 3 | $54 |
| Esperion Therapeutics, Inc. | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: Ozempic, OTEZLA, SPRAVATO, FREESTYLE LIBRE 3, MOUNJARO, NEXLETOL, XIFAXAN, JARDIANCE.
Industry payments across VA — which companies pay providers there.
